OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 26 filers reported holding OPIANT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,969 | -99.8% | 146,415 | -17.2% | 0.00% | +33.3% |
| Q3 2022 | $1,902,000 | -18.0% | 176,915 | -8.5% | 0.00% | 0.0% |
| Q2 2022 | $2,319,000 | -39.2% | 193,415 | +8.7% | 0.00% | -25.0% |
| Q1 2022 | $3,813,000 | -38.3% | 178,015 | -3.2% | 0.00% | -50.0% |
| Q4 2021 | $6,182,000 | +16.8% | 183,815 | -10.6% | 0.01% | +14.3% |
| Q3 2021 | $5,293,000 | +106.9% | 205,615 | +7.5% | 0.01% | +133.3% |
| Q2 2021 | $2,558,000 | +8.1% | 191,315 | -14.1% | 0.00% | 0.0% |
| Q1 2021 | $2,366,000 | +24.4% | 222,815 | -5.9% | 0.00% | +50.0% |
| Q4 2020 | $1,902,000 | +17.8% | 236,815 | +9.7% | 0.00% | 0.0% |
| Q3 2020 | $1,615,000 | -4.8% | 215,915 | +14.9% | 0.00% | +100.0% |
| Q2 2020 | $1,697,000 | +189.1% | 187,970 | +207.0% | 0.00% | 0.0% |
| Q1 2020 | $587,000 | -0.7% | 61,228 | +49.2% | 0.00% | – |
| Q4 2019 | $591,000 | +158.1% | 41,028 | +169.8% | 0.00% | – |
| Q3 2019 | $229,000 | – | 15,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 112,000 | $2,399,000 | 2.90% |
| Ovata Capital Management Ltd | 117,865 | $2,525,000 | 0.78% |
| HealthInvest Partners AB | 18,000 | $386,000 | 0.62% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $653,000 | 0.35% |
| Parkman Healthcare Partners LLC | 32,557 | $697,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 32,040 | $686,000 | 0.08% |
| DLD Asset Management, LP | 20,000 | $428,000 | 0.03% |
| Newbridge Financial Services Group, Inc. | 2,050 | $44,000 | 0.02% |
| Trexquant Investment LP | 12,013 | $257,000 | 0.01% |
| BAILARD, INC. | 15,042 | $322,000 | 0.01% |